M. Maral Mouradian,Steven Braithwaite,Michael Voronkov
申请号：
US15019218
公开号：
US09918980B2
申请日:
2016.02.09
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Methods of treating patients with dyskinesias, by administering a therapeutically effective amount of a dual-action μ-opioid receptor antagonist/κ-opioid receptor agonists or prodrug thereof to a subject in need thereof, sufficient to mitigate the dyskinesia. Alternatively, a combination of both a mu-opioid receptor antagonist or prodrug thereof, and a kappa-opioid receptor agonist or prodrug thereof can be administered, either together or separately.
